Minerva Neurosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Burlington, MA
NERV chart
What traders are saying about $NERV
Latest postsMinerva Neurosciences, Inc. news
- BlackRock reports a passive stake above 5% in Minerva Neurosciences (NERV).
Stock Titan ·
- Minerva Neurosciences Inc. Research & Ratings | NERV
Barron's ·
- Minerva Neurosciences, Inc Estimates – NASDAQ:NERV
TradingView ·
- Minerva Neurosciences (NERV) Holds Near $2.40 as Traders Eye Resistance - Range Breakout
https://www.dars.gov.et/ ·
- Minerva Neurosciences Inc. Advanced Charts | NERV
Barron's ·
- Minerva (NERV) Advances +9.05% as Buying Pressure Builds 2026-10-21 - Sector Sentiment
https://www.siam.in/ ·
- Minerva Neurosciences to Participate in Two Upcoming Investor Conferences
Yahoo Finance ·
- Minerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates
Yahoo Finance ·
- Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs
Yahoo Finance ·
- All You Need to Know About Minerva Neurosciences (NERV) Rating Upgrade to Buy
Yahoo Finance ·
- Minerva Neurosciences (NERV) Loses 37.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Yahoo Finance ·
- Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference
Yahoo Finance ·
Minerva Neurosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $0 | $0 | $0 |
| Net income | -$293.4M | $1.4M | -$30.0M | -$32.1M |
| Diluted EPS | $-34.67 | $0.19 | $-4.61 | $-6.01 |
| Total assets (year end) | $98.0M | $37.1M | $56.9M | $55.1M |
| Cash and equivalents (year end) | $82.3M | $21.4M | $40.9M | $36.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Minerva Neurosciences, Inc.
- Ticker
- NERV (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Burlington, MA
- Incorporated in
- MA
- Fiscal year end
- December 31
- SEC CIK
- 1598646
Frequently asked questions
What exchange is Minerva Neurosciences, Inc. listed on?
Minerva Neurosciences, Inc. trades on the Nasdaq under the ticker symbol NERV.
What industry is Minerva Neurosciences, Inc. in?
Minerva Neurosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Minerva Neurosciences, Inc. headquartered?
Minerva Neurosciences, Inc.'s business address on file with the SEC is in Burlington, MA.
When does Minerva Neurosciences, Inc.'s fiscal year end?
Minerva Neurosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Minerva Neurosciences, Inc. report?
Minerva Neurosciences, Inc. reported $0 in revenue for calendar year 2024, according to its SEC filings.